myTomorrows Secures $29M to Expand Patient Treatment Access

myTomorrows, a company dedicated to facilitating access to medical treatments, has announced it has secured $29,000,000 in investment capital from investors. The company's core mission is to enable earlier and better access to all possible treatment options for patients globally. It operates a digital platform designed to connect patients, physicians, and biopharmaceutical companies, facilitating access to clinical trials and expanded access programs. For patients and physicians, myTomorrows provides comprehensive information on available clinical trials and expanded access programs, along with guidance on how to access them. The company also offers dedicated Patient Navigators who support patients throughout their journey, with all these services provided free of charge to them. myTomorrows also supports BioPharma companies by making their clinical trials and expanded access programs more accessible. Its services for these partners include clinical trial recruitment, managing international expanded access programs, logistics, quality management, distribution, and real-world data collection. The company charges BioPharma companies for these specialized services. Currently, myTomorrows has assisted over 14,000 patients and 2,200 physicians, collaborating with over 200 sites globally. This funding round represents a significant investment in myTomorrows' continued growth and its mission to improve patient access to treatments. The company plans to use the newly secured capital to further scale its digital platform and expand its global operations, aiming to enhance its technological capabilities and broaden its reach to more patients and medical professionals worldwide. Looking ahead, the company aims to accelerate its mission of breaking barriers for eligible patients to receive information on and enroll in pre-approval treatment options. This strategic funding is expected to solidify myTomorrows' position as a key facilitator in the global pre-approval access ecosystem, driving continued growth and impact.